XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenues        
Product sales $ 96,000 $ 5,000 $ 181,000 $ 14,000
Cost of revenues        
Product sales 7,000 11,000 17,000 42,000
Service and other 0 55,000 0 119,000
Total cost of revenues 7,000 66,000 17,000 161,000
Gross profit (loss) 89,000 (61,000) 164,000 (147,000)
Operating expenses        
Selling, general and administrative 1,415,000 2,476,000 11,648,000 4,778,000
Research and development 134,000 2,396,000 374,000 5,511,000
Restructuring and impairment 0 3,527,000 0 3,527,000
Loss on impairment of goodwill 4,848,000 0 60,934,000 0
Total operating expenses 6,397,000 8,399,000 72,956,000 13,816,000
Operating loss (6,308,000) (8,460,000) (72,792,000) (13,963,000)
Other income, net        
Change in fair value of royalty payable 4,617 0 4,617 0
Interest income 119,000 0 188,000 0
Other (expense) income, net 4,000 12,000 11,000 20,000
Total other income, net 4,732,000 12,000 4,816,000 20,000
Loss from operations before income taxes (1,576,000) (8,448,000) (67,976,000) (13,943,000)
Income taxes 0 0 0 0
Net loss (1,576,000) (8,448,000) (67,976,000) (13,943,000)
Deemed dividends from the warrant inducement offer 0 0 (800,000) 0
Net loss attributable to common stockholders $ (1,576,000) $ (8,448,000) $ (68,776,000) $ (13,943,000)
Net loss per share attributable to common stockholders, basic and diluted $ (0.29) $ (13.07) $ (16.97) $ (0.03)
Weighted average common shares used in computing net loss per share, basic and diluted 5,364,383 646,361 4,052,700 525,924